Bata is India's largest footwear retailer of India. It is a part of the Bata Shoe Organisation and was incorporated in the year 1931. The company also manufactures footwear and has a wide retail network of over 1200 stores across India. It sells over... More
Colgate is present in oral care, personal care and household care products with oral care contributing more than 90% to overall revenues. Colgate dominates in this core business with market shares of 54.5% in toothpastes and 38.2% in toothbrushes. Th... More
BATA INDIA | COLGATE | BATA INDIA/ COLGATE |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 2,166.6 | 47.2 | 4,589.6% | View Chart |
P/BV | x | 10.6 | 28.6 | 37.2% | View Chart |
Dividend Yield | % | 0.3 | 1.5 | 16.9% |
![]() ![]() |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
BATA INDIA Mar-20 |
COLGATE Mar-19 |
BATA INDIA/ COLGATE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 1,897 | 1,365 | 139.0% | |
Low | Rs | 1,017 | 1,020 | 99.7% | |
Sales per share (Unadj.) | Rs | 237.8 | 164.1 | 144.9% | |
Earnings per share (Unadj.) | Rs | 25.6 | 28.5 | 89.8% | |
Cash flow per share (Unadj.) | Rs | 48.6 | 34.4 | 141.4% | |
Dividends per share (Unadj.) | Rs | 4.00 | 23.00 | 17.4% | |
Dividend yield (eoy) | % | 0.3 | 1.9 | 14.2% | |
Book value per share (Unadj.) | Rs | 147.4 | 53.2 | 277.0% | |
Shares outstanding (eoy) | m | 128.53 | 271.99 | 47.3% | |
Bonus/Rights/Conversions | - | - | - | ||
Price / Sales ratio | x | 6.1 | 7.3 | 84.3% | |
Avg P/E ratio | x | 56.9 | 41.8 | 136.1% | |
P/CF ratio (eoy) | x | 30.0 | 34.7 | 86.4% | |
Price / Book Value ratio | x | 9.9 | 22.4 | 44.1% | |
Dividend payout | % | 15.6 | 80.7 | 19.4% | |
Avg Mkt Cap | Rs m | 187,281 | 324,389 | 57.7% | |
No. of employees | `000 | 4.9 | 2.3 | 213.1% | |
Total wages/salary | Rs m | 3,764 | 2,959 | 127.2% | |
Avg. sales/employee | Rs Th | 6,220.5 | 19,359.8 | 32.1% | |
Avg. wages/employee | Rs Th | 766.2 | 1,283.7 | 59.7% | |
Avg. net profit/employee | Rs Th | 669.6 | 3,364.7 | 19.9% |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 30,561 | 44,624 | 68.5% | |
Other income | Rs m | 687 | 377 | 182.4% | |
Total revenues | Rs m | 31,248 | 45,001 | 69.4% | |
Gross profit | Rs m | 8,321 | 12,361 | 67.3% | |
Depreciation | Rs m | 2,958 | 1,592 | 185.8% | |
Interest | Rs m | 1,177 | 25 | 4,709.6% | |
Profit before tax | Rs m | 4,872 | 11,121 | 43.8% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 305 | 0.0% | |
Tax | Rs m | 1,583 | 3,670 | 43.1% | |
Profit after tax | Rs m | 3,290 | 7,756 | 42.4% | |
Gross profit margin | % | 27.2 | 27.7 | 98.3% | |
Effective tax rate | % | 32.5 | 33.0 | 98.4% | |
Net profit margin | % | 10.8 | 17.4 | 61.9% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 20,033 | 10,102 | 198.3% | |
Current liabilities | Rs m | 8,007 | 10,511 | 76.2% | |
Net working cap to sales | % | 39.3 | -0.9 | -4,288.9% | |
Current ratio | x | 2.5 | 1.0 | 260.3% | |
Inventory Days | Days | 104 | 20 | 513.2% | |
Debtors Days | Days | 8 | 17 | 44.0% | |
Net fixed assets | Rs m | 13,893 | 13,896 | 100.0% | |
Share capital | Rs m | 643 | 272 | 236.3% | |
"Free" reserves | Rs m | 18,297 | 14,196 | 128.9% | |
Net worth | Rs m | 18,939 | 14,468 | 130.9% | |
Long term debt | Rs m | 10,354 | 777 | 1,332.3% | |
Total assets | Rs m | 37,325 | 26,265 | 142.1% | |
Interest coverage | x | 5.1 | 445.8 | 1.2% | |
Debt to equity ratio | x | 0.5 | 0.1 | 1,017.8% | |
Sales to assets ratio | x | 0.8 | 1.7 | 48.2% | |
Return on assets | % | 12.0 | 29.6 | 40.4% | |
Return on equity | % | 17.4 | 53.6 | 32.4% | |
Return on capital | % | 20.7 | 75.1 | 27.5% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 202 | 2,007 | 10.1% | |
Fx outflow | Rs m | 3,047 | 7,191 | 42.4% | |
Net fx | Rs m | -2,845 | -5,184 | 54.9% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 5,817 | 9,830 | 59.2% | |
From Investments | Rs m | -1,890 | -957 | 197.5% | |
From Financial Activity | Rs m | -4,361 | -8,147 | 53.5% | |
Net Cashflow | Rs m | -434 | 726 | -59.7% |
Indian Promoters | % | 0.0 | 0.0 | - | |
Foreign collaborators | % | 53.0 | 51.0 | 103.9% | |
Indian inst/Mut Fund | % | 9.8 | 7.0 | 140.0% | |
FIIs | % | 20.1 | 20.0 | 100.5% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 17.1 | 22.1 | 77.4% | |
Shareholders | 83,621 | 131,569 | 63.6% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare BATA INDIA With: KARUTURI GLOBAL GILLETTE INDIA GODREJ INDUSTRIES GODREJ CONSUMER MARICO
Compare BATA INDIA With: UNILEVER PLC. (UK) P&G (US) HYPERMARCAS (Brazil)
The market scaled new life-time highs this week but it was the bears who took control. The benchmark indices, Sensex and Nifty ended mostly flat for the week but the momentum was in favour of the bears.
For the quarter ended September 2020, COLGATE has posted a net profit of Rs 3 bn (up 12.3% YoY). Sales on the other hand came in at Rs 13 bn (up 6.0% YoY). Read on for a complete analysis of COLGATE's quarterly results.
For the quarter ended June 2020, COLGATE has posted a net profit of Rs 2 bn (up 17.2% YoY). Sales on the other hand came in at Rs 10 bn (down 4.7% YoY). Read on for a complete analysis of COLGATE's quarterly results.
Here's an analysis of the annual report of BATA INDIA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of BATA INDIA. Also includes updates on the valuation of BATA INDIA.
For the quarter ended March 2020, COLGATE has posted a net profit of Rs 2 bn (up 3.3% YoY). Sales on the other hand came in at Rs 11 bn (down 7.1% YoY). Read on for a complete analysis of COLGATE's quarterly results.
For the quarter ended March 2020, BATA INDIA has posted a net profit of Rs 376 m (down 57.4% YoY). Sales on the other hand came in at Rs 6 bn (down 8.8% YoY). Read on for a complete analysis of BATA INDIA's quarterly results.
More Views on NewsWere you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...
In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
Our ace stock picker is ready to capitalise on a big growth opportunity.
The pandemic failed to thwart Richa's investing success formula for 2020.
More